Ventricular Arrhythmia in Cancer Patients: Mechanisms, Treatment Strategies and Future Avenues
出版年份 2023 全文链接
标题
Ventricular Arrhythmia in Cancer Patients: Mechanisms, Treatment Strategies and Future Avenues
作者
关键词
-
出版物
Arrhythmia & Electrophysiology Review
Volume 12, Issue -, Pages -
出版商
Radcliffe Media Media Ltd
发表日期
2023-05-30
DOI
10.15420/aer.2023.04
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Ventricular Arrhythmias and Sudden Death Events following Acalabrutinib initiation
- (2022) Seema A Bhat et al. BLOOD
- The association of cardiac arrhythmias with chimeric antigen receptor T cell therapy in hospitalised patients: Insights from National Inpatient Sample
- (2022) Sahith Reddy Thotamgari et al. EUROPEAN JOURNAL OF CANCER
- The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overview
- (2022) Eline L Giraud et al. LANCET ONCOLOGY
- Electrocardiographic features of immune checkpoint inhibitor associated myocarditis
- (2021) Daniel A Zlotoff et al. Journal for ImmunoTherapy of Cancer
- Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association
- (2021) Michael G. Fradley et al. CIRCULATION
- Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study
- (2021) Joe-Elie Salem et al. EUROPEAN HEART JOURNAL
- Cardiotoxicity associated with immune checkpoint inhibitor therapy: a meta‐analysis
- (2021) Nestor Rubio‐Infante et al. EUROPEAN JOURNAL OF HEART FAILURE
- Keeping immune checkpoint inhibitor myocarditis in check: advanced circulatory mechanical support as a bridge to recovery
- (2021) Ashley F. Stein‐Merlob et al. ESC Heart Failure
- Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
- (2021) Joerg Herrmann et al. EUROPEAN HEART JOURNAL
- Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy
- (2021) Adam Goldman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Safety Communications After US Food and Drug Administration Approval of Contemporary Cancer Therapies
- (2021) Janice M. Bonsu et al. JAMA Oncology
- Tyrosine Kinase Inhibitors-Induced Arrhythmias: From Molecular Mechanisms, Pharmacokinetics to Therapeutic Strategies
- (2021) Mengfei Cheng et al. Frontiers in Cardiovascular Medicine
- Prevalence and in-hospital outcomes of patients with malignancies undergoing de novo cardiac electronic device implantation in the USA
- (2020) Mohamed O Mohamed et al. EUROPACE
- Risk of QTc Prolongation Among Cancer Patients Treated with Tyrosine Kinase Inhibitors
- (2020) Anan A. Abu Rmilah et al. INTERNATIONAL JOURNAL OF CANCER
- Electrocardiographic characteristics of diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy
- (2020) Ziliang Chen et al. JOURNAL OF ELECTROCARDIOLOGY
- Ventricular tachycardia, premature ventricular contractions, and mortality in unselected patients with lung, colon, or pancreatic cancer: a prospective study
- (2020) Markus S Anker et al. EUROPEAN JOURNAL OF HEART FAILURE
- Electrocardiographic Characteristics of Breast Cancer Patients Treated with Chemotherapy
- (2020) Xufei Liang et al. Cardiology Research and Practice
- A current understanding of drug-induced QT prolongation and its implications for anticancer therapy
- (2019) Dan M Roden CARDIOVASCULAR RESEARCH
- Fragmented QRS formation and its predictors in patients with breast cancer receiving anthracycline-based chemotherapy
- (2019) Muhammet Dural et al. JOURNAL OF ELECTROCARDIOLOGY
- A Novel Predictor of Chemotherapeutic Cardiotoxicity in Patients with Non-Hodgkin Lymphoma
- (2019) Muhammet Gurdogan et al. Oncology Research and Treatment
- Association of Cardiac Resynchronization Therapy With Change in Left Ventricular Ejection Fraction in Patients With Chemotherapy-Induced Cardiomyopathy
- (2019) Jagmeet P. Singh et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cardiovascular Toxicities Associated With Ibrutinib
- (2019) Joe-Elie Salem et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiac Complications Associated With Checkpoint Inhibition: A Systematic Review of the Literature in an Important Emerging Area
- (2018) Hassan Mir et al. CANADIAN JOURNAL OF CARDIOLOGY
- MYOCARDITIS IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
- (2018) Syed Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Update on cardio-oncology: Novel cancer therapeutics and associated cardiotoxicities
- (2018) Avirup Guha et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Ventricular Arrhythmias Following Ibrutinib Initiation for Lymphoid Malignancies
- (2018) Avirup Guha et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Incidence of Cancer Treatment–Induced Arrhythmia Associated With Novel Targeted Chemotherapeutic Agents
- (2018) Andrew C. Nickel et al. Journal of the American Heart Association
- Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review
- (2017) Andreu Porta‐Sánchez et al. Journal of the American Heart Association
- Use and misuse of common terminology criteria for adverse events in cancer clinical trials
- (2016) Sheng Zhang et al. BMC CANCER
- Which QT Correction Formulae to Use for QT Monitoring?
- (2016) Bert Vandenberk et al. Journal of the American Heart Association
- Radiotherapy Induces Development of Fragmented QRS in Patients with Breast Cancer
- (2015) Adem Adar et al. Breast Care
- A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer
- (2013) Dana E. Rathkopf et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval)
- (2013) Rashmi R. Shah et al. DRUG SAFETY
- α-Lipoic acid protects against arsenic trioxide-induced acute QT prolongation in anesthetized guinea pigs
- (2013) Masafumi Kumazaki et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Electrocardiograms (ECGs) in phase I anticancer drug development: the MD Anderson Cancer Center experience with 8518 ECGs
- (2012) A. Naing et al. ANNALS OF ONCOLOGY
- Effect of selection of QTc formula on eligibility of cancer patients for phase I clinical trials
- (2012) Mitesh J. Borad et al. INVESTIGATIONAL NEW DRUGS
- Incidence and Risk of QTc Interval Prolongation among Cancer Patients Treated with Vandetanib: A Systematic Review and Meta-analysis
- (2012) Jiajie Zang et al. PLoS One
- Benign cardiac tumours, malignant arrhythmias
- (2011) Kimberley A. Myers et al. CANADIAN JOURNAL OF CARDIOLOGY
- Cardiac Tumors and Associated Arrhythmias in Pediatric Patients, With Observations on Surgical Therapy for Ventricular Tachycardia
- (2011) Christina Y. Miyake et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Myocarditis
- (2011) Sandeep Sagar et al. LANCET
- Long-term Cause-Specific Mortality Among Survivors of Childhood Cancer
- (2010) Raoul C. Reulen JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Assessing proarrhythmic potential of drugs when optimal studies are infeasible
- (2009) Edwin P. Rock et al. AMERICAN HEART JOURNAL
- Dexrazoxane protects the heart from acute doxorubicin-induced QT prolongation: a key role for IKs
- (2009) J Ducroq et al. BRITISH JOURNAL OF PHARMACOLOGY
- Introducing a new entity: chemotherapy-induced arrhythmia
- (2009) M. Guglin et al. EUROPACE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started